Involvement of interleukin-6 and tumor necrosis factor α in CYP3A11 and 2C29 down-regulation by bacillus Calmette-Guerin and, lipopolysaccharide in mouse liver

Drug Metabolism and Disposition

Volumn 32, Issue 7, 2004, Pages 707-714

  Ashino, Takashi ^a   Oguro, Takiko ^b   Shioda, Seiji ^a   Horai, Reiko ^c   Asano, Masahide ^d   Sekikawa, Kenji ^e   Iwakura, Yoichiro ^c   Numazawa, Satoshi ^a   Yoshida, Takemi ^a  

^a SHOWA UNIVERSITY   (Japan)

^b ALCON RESEARCH LTD   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

^e NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYTOCHROME P450; CYTOCHROME P450 2C29; CYTOCHROME P450 3A11; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; KNOCKOUT MOUSE; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BCG VACCINE; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICROSOMES, LIVER; OXIDOREDUCTASES, N-DEMETHYLATING; PHOSPHORYLATION; RNA, MESSENGER; SPECIES SPECIFICITY; STEROID HYDROXYLASES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MYCOBACTERIUM BOVIS BCG;

EID: 3042594859     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.32.7.707     Document Type: Article

References (32)

1. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
2. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
3. De Boer EC, De Jong WH, Steerenberg PA, Aarden LA, Tetteroo E, De Groot ER, Van der Meijden AP, Vegt PD, Debruyne FM, and Ruitenberg EJ (1992) Induction of urinary interleukin-1 (IL-1), IL-2, IL-6 and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guerin in superficial bladder cancer. Cancer Immunol Immunother 34:306-312.
4. Dulak J and Jozkowicz A (2003) Carbon monoxide - a "new" gaseous modulator of gene expression. Acta Biochim Pol 50:31-47.
5. Gonzalez FJ (1988) The molecular biology of cytochrome P450s. Pharmacol Rev 40:243-288.
6. Gonzalez OY, Musher DM, Brar I, Furgeson S, Boktour MR, Septimus EJ, Hamill RJ, and Graviss EA (2003) Spectrum of bacille Calmette-Guerin (BCG) infection after intravesical BCG immunotherapy. Clin Infect Dis 36:140-148.
7. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, and Graeve L (1998) Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334:297-314.
8. Horai R, Asano M, Sudo K, Kanuka H, Suzuki M, Nishihara M, Takahashi M, and Iwakura Y (1998) Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 187:1463-1475.
9. Iber H, Sewer MB, Barclay TB, Mitchell SR, Li T, and Morgan ET (1999) Modulation of drug metabolism in infectious and inflammatory diseases. Drug Metab Rev 31:29-41.
10. Imaoka S, Terano Y, and Funae Y (1987) Purification and characterization of two constitutive cytochromes P-450 (F-1 and F-2) from adult female rats: identification of P-450F-1 as the phenobarbital-inducible cytochrome P-450 in male rat liver. Biochim Biophys Acta 916:358-367.
11. Jover R, Bort R, Gomez-Lechon MJ, and Castell JV (2002) Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved. FASEB J 16:1799-1801.
12. Kobayashi Y, Ohshiro N, Suzuki M, Sasaki T, Tokuyama S, Yoshida T, and Yamamoto T (2000) Sex-related effect of hemin on cytochrome P450 and drug-metabolizing enzymes in rat liver. J Toxicol Sci 25:213-222.
13. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, and Kohler G (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (Lond) 368:339-342.
14. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 277:680-685.
15. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
16. Matsuura Y, Watanabe H, Fukuda T, Yoshida T, and Kuroiwa Y (1985) A sustained increase of microsomal heme oxygenase activity following treatment of rats with Bacillus Calmette-Guerin and Corynebacterium parvum: its possible relation to the decrease of cytochrome P-450 content. J Pharmacobio-Dyn 8:669-678.
17. McMurray DN (2003) Recent progress in the development and testing of vaccines against human tuberculosis. Int J Parasitol 33:547-554.
18. Morgan ET (1997) Regulation of cytochromes P450 during inflammation and infection. Drug Metab Rev 29:1129-1188.
19. Morgan ET (2001) Regulation of cytochrome p450 by inflammatory mediators: why and how? Drug Metab Dispos 29:207-212.
20. Morgan ET, Li-Masters T, and Cheng PY (2002) Mechanisms of cytochrome P450 regulation by inflammatory mediators. Toxicology 181-182:207-210.
21. Nseyo UO and Lamm DL (1997) Immunotherapy of bladder cancer. Semin Surg Oncol 13:342-349.
22. O'Donnell MA, Luo Y, Chen X, Szilvasi A, Hunter SE, and Clinton SK (1999) Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Guerin. J Immunol 163:4246-4252.
23. Oguro T, Takahashi Y, Ashino T, Takaki A, Shioda S, Horai R, Asano M, Sekikawa K, Iwakura Y, and Yoshida T (2002) Involvement of tumor necrosis factor alpha, rather than interleukin-1alpha/beta or nitric oxides in the heme oxygenase-1 gene expression by lipopolysaccharide in the mouse liver. FEBS Lett 516:63-66.
24. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
25. Pan J, Xiang Q, Ball S, Scatina J, Kao J, and Hong JY (2003) Lipopolysaccharide-mediated modulation of cytochromes p450 in stat1 null mice. Drug Metab Dispos 31:392-397.
26. Sewer MB and Morgan ET (1997) Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1 beta and endotoxin in primary rat hepatocytes. Biochem Pharmacol 54:729-737.
27. Siewert E, Bort R, Kluge R, Heinrich PC, Castell J, and Jover R (2000) Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent. Hepatology 32:49-55.
28. Tagawa Y, Sekikawa K, and Iwakura Y (1997) Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol 159:1418-1428.
29. Takemura S, Minamiyama Y, Imaoka S, Funae Y, Hirohashi K, Inoue M, and Kinoshita H (1999) Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia. J Hepatol 30:1035-1044.
30. Van der Hoeven T (1984) Assay of hepatic microsomal testosterone hydroxylases by high-performance liquid chromatography. Anal Biochem 138:57-65.
31. Yasui H, Deo K, Ogura Y, Yoshida H, Shiraga T, Kagayama A, and Sakurai H (2002) Evidence for singlet oxygen involvement in rat and human cytochrome P450-dependent substrate Oxidations. Drug Metab Pharmacokinet 17:416-426.
32. Zhang GL, Wang YH, Ni W, Teng HL, and Lin ZB (2002) Hepatoprotective role of Ganoderma lucidum polysaccharide against BCG-induced immune liver injury in mice. World J Gastroenterol 8:728-733.